3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
51
Leukemia
41
Burkitt Lymphoma
23
Lymphoma
17
Leukemia, Biphenotypic, Acute
13
Leukemia, Myeloid, Acute
12
Myelodysplastic Syndromes
9
Lymphoma, Non-Hodgkin
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Lymphocytic, Chronic, B-Cell
7
Multiple Myeloma
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Follicular
6
Leukemia, Myelomonocytic, Chronic
6
Hodgkin Disease
6
Blast Crisis
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms, Plasma Cell
4
Neoplasm Metastasis
4
Myeloproliferative Disorders
4
Lymphoma, Mantle-Cell
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Accelerated Phase
4
Hematologic Neoplasms
4
Primary Myelofibrosis
3
Pancreatic Neoplasms
3
Lymphoma, Large-Cell, Anaplastic
3
Dendritic Cell Sarcoma, Interdigitating
3
Interventions
Doxorubicin
2
hydrocortisone hemisuccinate
1
Vincristine
1
Razoxane
1
Radiotherapy
1
Prednisone
1
Methotrexate
1
Mercaptopurine
1
Medical History Taking
1
Leucovorin
1
Laser-Doppler Flowmetry
1
Hydrocortisone
1
Exercise
1
Electrocardiography
1
Echocardiography, Stress
1
Dexrazoxane
1
Cytarabine
1
Blood Cell Count
1
Asparaginase
1
Anthropometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Leucovorin
×
Other hematologic neoplasm
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled